Biodefense Market - Global Outlook and Forecast 2021-2027
![](/report_cover/11201/biodefense-market-global-outlook-n-forecast-2021-2027_en.gif)
This report contains market size and forecasts of Biodefense in Global, including the following market information:
Global Biodefense Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Biodefense market was valued at 1097.1 million in 2020 and is projected to reach US$ 1437.3 million by 2027, at a CAGR of 7.0% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biodefense companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biodefense Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Biodefense Market Segment Percentages, By Type, 2020 (%)
China Biodefense Market Segment Percentages, By Application, 2020 (%)
Global Biodefense Market Segment Percentages, By Region and Country, 2020 (%)
The report also provides analysis of leading market participants including:
Total Biodefense Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Biodefense Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Global Biodefense Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Biodefense market was valued at 1097.1 million in 2020 and is projected to reach US$ 1437.3 million by 2027, at a CAGR of 7.0% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biodefense companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biodefense Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Biodefense Market Segment Percentages, By Type, 2020 (%)
- Anthrax
- Smallpox
- Botulism
- Radiation/Nuclear
- Others
China Biodefense Market Segment Percentages, By Application, 2020 (%)
- US Military Market
- US Civilian Market
- Non - US Market
Global Biodefense Market Segment Percentages, By Region and Country, 2020 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Total Biodefense Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Biodefense Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
- Emergent Biosolutions
- Hytest
- GSK
- Sanofi
- PharmAthene
- Bavarian Nordic
- SIGA Technologies
- Arbutus Biopharma
- DynPort Vaccine
- Xoma Corporation
- Ichor Medical Systems
- Aeolus Pharmaceuticals
- Achaogen
- Elusys Therapeutics
- Dynavax Technologies
- Cleveland BioLabs
- Soligenix
- Alnylam Pharmaceuticals
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Biodefense Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biodefense Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL BIODEFENSE OVERALL MARKET SIZE
2.1 Global Biodefense Market Size: 2021 VS 2027
2.2 Global Biodefense Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Biodefense Players in Global Market
3.2 Top Global Biodefense Companies Ranked by Revenue
3.3 Global Biodefense Revenue by Companies
3.4 Top 3 and Top 5 Biodefense Companies in Global Market, by Revenue in 2020
3.5 Global Companies Biodefense Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biodefense Players in Global Market
3.6.1 List of Global Tier 1 Biodefense Companies
3.6.2 List of Global Tier 2 and Tier 3 Biodefense Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Biodefense Market Size Markets, 2021 & 2027
4.1.2 Anthrax
4.1.3 Smallpox
4.1.4 Botulism
4.1.5 Radiation/Nuclear
4.1.6 Others
4.2 By Type - Global Biodefense Revenue & Forecasts
4.2.1 By Type - Global Biodefense Revenue, 2016-2021
4.2.2 By Type - Global Biodefense Revenue, 2022-2027
4.2.3 By Type - Global Biodefense Revenue Market Share, 2016-2027
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Biodefense Market Size, 2021 & 2027
5.1.2 US Military Market
5.1.3 US Civilian Market
5.1.4 Non - US Market
5.2 By Application - Global Biodefense Revenue & Forecasts
5.2.1 By Application - Global Biodefense Revenue, 2016-2021
5.2.2 By Application - Global Biodefense Revenue, 2022-2027
5.2.3 By Application - Global Biodefense Revenue Market Share, 2016-2027
6 SIGHTS BY REGION
6.1 By Region - Global Biodefense Market Size, 2021 & 2027
6.2 By Region - Global Biodefense Revenue & Forecasts
6.2.1 By Region - Global Biodefense Revenue, 2016-2021
6.2.2 By Region - Global Biodefense Revenue, 2022-2027
6.2.3 By Region - Global Biodefense Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Biodefense Revenue, 2016-2027
6.3.2 US Biodefense Market Size, 2016-2027
6.3.3 Canada Biodefense Market Size, 2016-2027
6.3.4 Mexico Biodefense Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Biodefense Revenue, 2016-2027
6.4.2 Germany Biodefense Market Size, 2016-2027
6.4.3 France Biodefense Market Size, 2016-2027
6.4.4 U.K. Biodefense Market Size, 2016-2027
6.4.5 Italy Biodefense Market Size, 2016-2027
6.4.6 Russia Biodefense Market Size, 2016-2027
6.4.7 Nordic Countries Biodefense Market Size, 2016-2027
6.4.8 Benelux Biodefense Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Biodefense Revenue, 2016-2027
6.5.2 China Biodefense Market Size, 2016-2027
6.5.3 Japan Biodefense Market Size, 2016-2027
6.5.4 South Korea Biodefense Market Size, 2016-2027
6.5.5 Southeast Asia Biodefense Market Size, 2016-2027
6.5.6 India Biodefense Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Biodefense Revenue, 2016-2027
6.6.2 Brazil Biodefense Market Size, 2016-2027
6.6.3 Argentina Biodefense Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Biodefense Revenue, 2016-2027
6.7.2 Turkey Biodefense Market Size, 2016-2027
6.7.3 Israel Biodefense Market Size, 2016-2027
6.7.4 Saudi Arabia Biodefense Market Size, 2016-2027
6.7.5 UAE Biodefense Market Size, 2016-2027
7 PLAYERS PROFILES
7.1 Emergent Biosolutions
7.1.1 Emergent Biosolutions Corporate Summary
7.1.2 Emergent Biosolutions Business Overview
7.1.3 Emergent Biosolutions Biodefense Major Product Offerings
7.1.4 Emergent Biosolutions Biodefense Revenue in Global (2016-2021)
7.1.5 Emergent Biosolutions Key News
7.2 Hytest
7.2.1 Hytest Corporate Summary
7.2.2 Hytest Business Overview
7.2.3 Hytest Biodefense Major Product Offerings
7.2.4 Hytest Biodefense Revenue in Global (2016-2021)
7.2.5 Hytest Key News
7.3 GSK
7.3.1 GSK Corporate Summary
7.3.2 GSK Business Overview
7.3.3 GSK Biodefense Major Product Offerings
7.3.4 GSK Biodefense Revenue in Global (2016-2021)
7.3.5 GSK Key News
7.4 Sanofi
7.4.1 Sanofi Corporate Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Biodefense Major Product Offerings
7.4.4 Sanofi Biodefense Revenue in Global (2016-2021)
7.4.5 Sanofi Key News
7.5 PharmAthene
7.5.1 PharmAthene Corporate Summary
7.5.2 PharmAthene Business Overview
7.5.3 PharmAthene Biodefense Major Product Offerings
7.5.4 PharmAthene Biodefense Revenue in Global (2016-2021)
7.5.5 PharmAthene Key News
7.6 Bavarian Nordic
7.6.1 Bavarian Nordic Corporate Summary
7.6.2 Bavarian Nordic Business Overview
7.6.3 Bavarian Nordic Biodefense Major Product Offerings
7.6.4 Bavarian Nordic Biodefense Revenue in Global (2016-2021)
7.6.5 Bavarian Nordic Key News
7.7 SIGA Technologies
7.7.1 SIGA Technologies Corporate Summary
7.7.2 SIGA Technologies Business Overview
7.7.3 SIGA Technologies Biodefense Major Product Offerings
7.4.4 SIGA Technologies Biodefense Revenue in Global (2016-2021)
7.7.5 SIGA Technologies Key News
7.8 Arbutus Biopharma
7.8.1 Arbutus Biopharma Corporate Summary
7.8.2 Arbutus Biopharma Business Overview
7.8.3 Arbutus Biopharma Biodefense Major Product Offerings
7.8.4 Arbutus Biopharma Biodefense Revenue in Global (2016-2021)
7.8.5 Arbutus Biopharma Key News
7.9 DynPort Vaccine
7.9.1 DynPort Vaccine Corporate Summary
7.9.2 DynPort Vaccine Business Overview
7.9.3 DynPort Vaccine Biodefense Major Product Offerings
7.9.4 DynPort Vaccine Biodefense Revenue in Global (2016-2021)
7.9.5 DynPort Vaccine Key News
7.10 Xoma Corporation
7.10.1 Xoma Corporation Corporate Summary
7.10.2 Xoma Corporation Business Overview
7.10.3 Xoma Corporation Biodefense Major Product Offerings
7.10.4 Xoma Corporation Biodefense Revenue in Global (2016-2021)
7.10.5 Xoma Corporation Key News
7.11 Ichor Medical Systems
7.11.1 Ichor Medical Systems Corporate Summary
7.11.2 Ichor Medical Systems Business Overview
7.11.3 Ichor Medical Systems Biodefense Major Product Offerings
7.11.4 Ichor Medical Systems Biodefense Revenue in Global (2016-2021)
7.11.5 Ichor Medical Systems Key News
7.12 Aeolus Pharmaceuticals
7.12.1 Aeolus Pharmaceuticals Corporate Summary
7.12.2 Aeolus Pharmaceuticals Business Overview
7.12.3 Aeolus Pharmaceuticals Biodefense Major Product Offerings
7.12.4 Aeolus Pharmaceuticals Biodefense Revenue in Global (2016-2021)
7.12.5 Aeolus Pharmaceuticals Key News
7.13 Achaogen
7.13.1 Achaogen Corporate Summary
7.13.2 Achaogen Business Overview
7.13.3 Achaogen Biodefense Major Product Offerings
7.13.4 Achaogen Biodefense Revenue in Global (2016-2021)
7.13.5 Achaogen Key News
7.14 Elusys Therapeutics
7.14.1 Elusys Therapeutics Corporate Summary
7.14.2 Elusys Therapeutics Business Overview
7.14.3 Elusys Therapeutics Biodefense Major Product Offerings
7.14.4 Elusys Therapeutics Biodefense Revenue in Global (2016-2021)
7.14.5 Elusys Therapeutics Key News
7.15 Dynavax Technologies
7.15.1 Dynavax Technologies Corporate Summary
7.15.2 Dynavax Technologies Business Overview
7.15.3 Dynavax Technologies Biodefense Major Product Offerings
7.15.4 Dynavax Technologies Biodefense Revenue in Global (2016-2021)
7.15.5 Dynavax Technologies Key News
7.16 Cleveland BioLabs
7.16.1 Cleveland BioLabs Corporate Summary
7.16.2 Cleveland BioLabs Business Overview
7.16.3 Cleveland BioLabs Biodefense Major Product Offerings
7.16.4 Cleveland BioLabs Biodefense Revenue in Global (2016-2021)
7.16.5 Cleveland BioLabs Key News
7.17 Soligenix
7.17.1 Soligenix Corporate Summary
7.17.2 Soligenix Business Overview
7.17.3 Soligenix Biodefense Major Product Offerings
7.17.4 Soligenix Biodefense Revenue in Global (2016-2021)
7.17.5 Soligenix Key News
7.18 Alnylam Pharmaceuticals
7.18.1 Alnylam Pharmaceuticals Corporate Summary
7.18.2 Alnylam Pharmaceuticals Business Overview
7.18.3 Alnylam Pharmaceuticals Biodefense Major Product Offerings
7.18.4 Alnylam Pharmaceuticals Biodefense Revenue in Global (2016-2021)
7.18.5 Alnylam Pharmaceuticals Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Biodefense Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biodefense Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL BIODEFENSE OVERALL MARKET SIZE
2.1 Global Biodefense Market Size: 2021 VS 2027
2.2 Global Biodefense Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Biodefense Players in Global Market
3.2 Top Global Biodefense Companies Ranked by Revenue
3.3 Global Biodefense Revenue by Companies
3.4 Top 3 and Top 5 Biodefense Companies in Global Market, by Revenue in 2020
3.5 Global Companies Biodefense Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biodefense Players in Global Market
3.6.1 List of Global Tier 1 Biodefense Companies
3.6.2 List of Global Tier 2 and Tier 3 Biodefense Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Biodefense Market Size Markets, 2021 & 2027
4.1.2 Anthrax
4.1.3 Smallpox
4.1.4 Botulism
4.1.5 Radiation/Nuclear
4.1.6 Others
4.2 By Type - Global Biodefense Revenue & Forecasts
4.2.1 By Type - Global Biodefense Revenue, 2016-2021
4.2.2 By Type - Global Biodefense Revenue, 2022-2027
4.2.3 By Type - Global Biodefense Revenue Market Share, 2016-2027
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Biodefense Market Size, 2021 & 2027
5.1.2 US Military Market
5.1.3 US Civilian Market
5.1.4 Non - US Market
5.2 By Application - Global Biodefense Revenue & Forecasts
5.2.1 By Application - Global Biodefense Revenue, 2016-2021
5.2.2 By Application - Global Biodefense Revenue, 2022-2027
5.2.3 By Application - Global Biodefense Revenue Market Share, 2016-2027
6 SIGHTS BY REGION
6.1 By Region - Global Biodefense Market Size, 2021 & 2027
6.2 By Region - Global Biodefense Revenue & Forecasts
6.2.1 By Region - Global Biodefense Revenue, 2016-2021
6.2.2 By Region - Global Biodefense Revenue, 2022-2027
6.2.3 By Region - Global Biodefense Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Biodefense Revenue, 2016-2027
6.3.2 US Biodefense Market Size, 2016-2027
6.3.3 Canada Biodefense Market Size, 2016-2027
6.3.4 Mexico Biodefense Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Biodefense Revenue, 2016-2027
6.4.2 Germany Biodefense Market Size, 2016-2027
6.4.3 France Biodefense Market Size, 2016-2027
6.4.4 U.K. Biodefense Market Size, 2016-2027
6.4.5 Italy Biodefense Market Size, 2016-2027
6.4.6 Russia Biodefense Market Size, 2016-2027
6.4.7 Nordic Countries Biodefense Market Size, 2016-2027
6.4.8 Benelux Biodefense Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Biodefense Revenue, 2016-2027
6.5.2 China Biodefense Market Size, 2016-2027
6.5.3 Japan Biodefense Market Size, 2016-2027
6.5.4 South Korea Biodefense Market Size, 2016-2027
6.5.5 Southeast Asia Biodefense Market Size, 2016-2027
6.5.6 India Biodefense Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Biodefense Revenue, 2016-2027
6.6.2 Brazil Biodefense Market Size, 2016-2027
6.6.3 Argentina Biodefense Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Biodefense Revenue, 2016-2027
6.7.2 Turkey Biodefense Market Size, 2016-2027
6.7.3 Israel Biodefense Market Size, 2016-2027
6.7.4 Saudi Arabia Biodefense Market Size, 2016-2027
6.7.5 UAE Biodefense Market Size, 2016-2027
7 PLAYERS PROFILES
7.1 Emergent Biosolutions
7.1.1 Emergent Biosolutions Corporate Summary
7.1.2 Emergent Biosolutions Business Overview
7.1.3 Emergent Biosolutions Biodefense Major Product Offerings
7.1.4 Emergent Biosolutions Biodefense Revenue in Global (2016-2021)
7.1.5 Emergent Biosolutions Key News
7.2 Hytest
7.2.1 Hytest Corporate Summary
7.2.2 Hytest Business Overview
7.2.3 Hytest Biodefense Major Product Offerings
7.2.4 Hytest Biodefense Revenue in Global (2016-2021)
7.2.5 Hytest Key News
7.3 GSK
7.3.1 GSK Corporate Summary
7.3.2 GSK Business Overview
7.3.3 GSK Biodefense Major Product Offerings
7.3.4 GSK Biodefense Revenue in Global (2016-2021)
7.3.5 GSK Key News
7.4 Sanofi
7.4.1 Sanofi Corporate Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Biodefense Major Product Offerings
7.4.4 Sanofi Biodefense Revenue in Global (2016-2021)
7.4.5 Sanofi Key News
7.5 PharmAthene
7.5.1 PharmAthene Corporate Summary
7.5.2 PharmAthene Business Overview
7.5.3 PharmAthene Biodefense Major Product Offerings
7.5.4 PharmAthene Biodefense Revenue in Global (2016-2021)
7.5.5 PharmAthene Key News
7.6 Bavarian Nordic
7.6.1 Bavarian Nordic Corporate Summary
7.6.2 Bavarian Nordic Business Overview
7.6.3 Bavarian Nordic Biodefense Major Product Offerings
7.6.4 Bavarian Nordic Biodefense Revenue in Global (2016-2021)
7.6.5 Bavarian Nordic Key News
7.7 SIGA Technologies
7.7.1 SIGA Technologies Corporate Summary
7.7.2 SIGA Technologies Business Overview
7.7.3 SIGA Technologies Biodefense Major Product Offerings
7.4.4 SIGA Technologies Biodefense Revenue in Global (2016-2021)
7.7.5 SIGA Technologies Key News
7.8 Arbutus Biopharma
7.8.1 Arbutus Biopharma Corporate Summary
7.8.2 Arbutus Biopharma Business Overview
7.8.3 Arbutus Biopharma Biodefense Major Product Offerings
7.8.4 Arbutus Biopharma Biodefense Revenue in Global (2016-2021)
7.8.5 Arbutus Biopharma Key News
7.9 DynPort Vaccine
7.9.1 DynPort Vaccine Corporate Summary
7.9.2 DynPort Vaccine Business Overview
7.9.3 DynPort Vaccine Biodefense Major Product Offerings
7.9.4 DynPort Vaccine Biodefense Revenue in Global (2016-2021)
7.9.5 DynPort Vaccine Key News
7.10 Xoma Corporation
7.10.1 Xoma Corporation Corporate Summary
7.10.2 Xoma Corporation Business Overview
7.10.3 Xoma Corporation Biodefense Major Product Offerings
7.10.4 Xoma Corporation Biodefense Revenue in Global (2016-2021)
7.10.5 Xoma Corporation Key News
7.11 Ichor Medical Systems
7.11.1 Ichor Medical Systems Corporate Summary
7.11.2 Ichor Medical Systems Business Overview
7.11.3 Ichor Medical Systems Biodefense Major Product Offerings
7.11.4 Ichor Medical Systems Biodefense Revenue in Global (2016-2021)
7.11.5 Ichor Medical Systems Key News
7.12 Aeolus Pharmaceuticals
7.12.1 Aeolus Pharmaceuticals Corporate Summary
7.12.2 Aeolus Pharmaceuticals Business Overview
7.12.3 Aeolus Pharmaceuticals Biodefense Major Product Offerings
7.12.4 Aeolus Pharmaceuticals Biodefense Revenue in Global (2016-2021)
7.12.5 Aeolus Pharmaceuticals Key News
7.13 Achaogen
7.13.1 Achaogen Corporate Summary
7.13.2 Achaogen Business Overview
7.13.3 Achaogen Biodefense Major Product Offerings
7.13.4 Achaogen Biodefense Revenue in Global (2016-2021)
7.13.5 Achaogen Key News
7.14 Elusys Therapeutics
7.14.1 Elusys Therapeutics Corporate Summary
7.14.2 Elusys Therapeutics Business Overview
7.14.3 Elusys Therapeutics Biodefense Major Product Offerings
7.14.4 Elusys Therapeutics Biodefense Revenue in Global (2016-2021)
7.14.5 Elusys Therapeutics Key News
7.15 Dynavax Technologies
7.15.1 Dynavax Technologies Corporate Summary
7.15.2 Dynavax Technologies Business Overview
7.15.3 Dynavax Technologies Biodefense Major Product Offerings
7.15.4 Dynavax Technologies Biodefense Revenue in Global (2016-2021)
7.15.5 Dynavax Technologies Key News
7.16 Cleveland BioLabs
7.16.1 Cleveland BioLabs Corporate Summary
7.16.2 Cleveland BioLabs Business Overview
7.16.3 Cleveland BioLabs Biodefense Major Product Offerings
7.16.4 Cleveland BioLabs Biodefense Revenue in Global (2016-2021)
7.16.5 Cleveland BioLabs Key News
7.17 Soligenix
7.17.1 Soligenix Corporate Summary
7.17.2 Soligenix Business Overview
7.17.3 Soligenix Biodefense Major Product Offerings
7.17.4 Soligenix Biodefense Revenue in Global (2016-2021)
7.17.5 Soligenix Key News
7.18 Alnylam Pharmaceuticals
7.18.1 Alnylam Pharmaceuticals Corporate Summary
7.18.2 Alnylam Pharmaceuticals Business Overview
7.18.3 Alnylam Pharmaceuticals Biodefense Major Product Offerings
7.18.4 Alnylam Pharmaceuticals Biodefense Revenue in Global (2016-2021)
7.18.5 Alnylam Pharmaceuticals Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Biodefense Market Opportunities & Trends in Global Market
Table 2. Biodefense Market Drivers in Global Market
Table 3. Biodefense Market Restraints in Global Market
Table 4. Key Players of Biodefense in Global Market
Table 5. Top Biodefense Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Biodefense Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Biodefense Revenue Share by Companies, 2016-2021
Table 8. Global Companies Biodefense Product Type
Table 9. List of Global Tier 1 Biodefense Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biodefense Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Biodefense Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Biodefense Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Biodefense Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Biodefense Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Biodefense Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Biodefense Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Biodefense Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Biodefense Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Biodefense Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Biodefense Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Biodefense Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Biodefense Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Biodefense Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Biodefense Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Biodefense Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Biodefense Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Biodefense Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Biodefense Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Biodefense Revenue, (US$, Mn), 2022-2027
Table 30. Emergent Biosolutions Corporate Summary
Table 31. Emergent Biosolutions Biodefense Product Offerings
Table 32. Emergent Biosolutions Biodefense Revenue (US$, Mn), (2016-2021)
Table 33. Hytest Corporate Summary
Table 34. Hytest Biodefense Product Offerings
Table 35. Hytest Biodefense Revenue (US$, Mn), (2016-2021)
Table 36. GSK Corporate Summary
Table 37. GSK Biodefense Product Offerings
Table 38. GSK Biodefense Revenue (US$, Mn), (2016-2021)
Table 39. Sanofi Corporate Summary
Table 40. Sanofi Biodefense Product Offerings
Table 41. Sanofi Biodefense Revenue (US$, Mn), (2016-2021)
Table 42. PharmAthene Corporate Summary
Table 43. PharmAthene Biodefense Product Offerings
Table 44. PharmAthene Biodefense Revenue (US$, Mn), (2016-2021)
Table 45. Bavarian Nordic Corporate Summary
Table 46. Bavarian Nordic Biodefense Product Offerings
Table 47. Bavarian Nordic Biodefense Revenue (US$, Mn), (2016-2021)
Table 48. SIGA Technologies Corporate Summary
Table 49. SIGA Technologies Biodefense Product Offerings
Table 50. SIGA Technologies Biodefense Revenue (US$, Mn), (2016-2021)
Table 51. Arbutus Biopharma Corporate Summary
Table 52. Arbutus Biopharma Biodefense Product Offerings
Table 53. Arbutus Biopharma Biodefense Revenue (US$, Mn), (2016-2021)
Table 54. DynPort Vaccine Corporate Summary
Table 55. DynPort Vaccine Biodefense Product Offerings
Table 56. DynPort Vaccine Biodefense Revenue (US$, Mn), (2016-2021)
Table 57. Xoma Corporation Corporate Summary
Table 58. Xoma Corporation Biodefense Product Offerings
Table 59. Xoma Corporation Biodefense Revenue (US$, Mn), (2016-2021)
Table 60. Ichor Medical Systems Corporate Summary
Table 61. Ichor Medical Systems Biodefense Product Offerings
Table 62. Ichor Medical Systems Biodefense Revenue (US$, Mn), (2016-2021)
Table 63. Aeolus Pharmaceuticals Corporate Summary
Table 64. Aeolus Pharmaceuticals Biodefense Product Offerings
Table 65. Aeolus Pharmaceuticals Biodefense Revenue (US$, Mn), (2016-2021)
Table 66. Achaogen Corporate Summary
Table 67. Achaogen Biodefense Product Offerings
Table 68. Achaogen Biodefense Revenue (US$, Mn), (2016-2021)
Table 69. Elusys Therapeutics Corporate Summary
Table 70. Elusys Therapeutics Biodefense Product Offerings
Table 71. Elusys Therapeutics Biodefense Revenue (US$, Mn), (2016-2021)
Table 72. Dynavax Technologies Corporate Summary
Table 73. Dynavax Technologies Biodefense Product Offerings
Table 74. Dynavax Technologies Biodefense Revenue (US$, Mn), (2016-2021)
Table 75. Cleveland BioLabs Corporate Summary
Table 76. Cleveland BioLabs Biodefense Product Offerings
Table 77. Cleveland BioLabs Biodefense Revenue (US$, Mn), (2016-2021)
Table 78. Soligenix Corporate Summary
Table 79. Soligenix Biodefense Product Offerings
Table 80. Soligenix Biodefense Revenue (US$, Mn), (2016-2021)
Table 81. Alnylam Pharmaceuticals Corporate Summary
Table 82. Alnylam Pharmaceuticals Biodefense Product Offerings
Table 83. Alnylam Pharmaceuticals Biodefense Revenue (US$, Mn), (2016-2021)
Table 1. Biodefense Market Opportunities & Trends in Global Market
Table 2. Biodefense Market Drivers in Global Market
Table 3. Biodefense Market Restraints in Global Market
Table 4. Key Players of Biodefense in Global Market
Table 5. Top Biodefense Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Biodefense Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Biodefense Revenue Share by Companies, 2016-2021
Table 8. Global Companies Biodefense Product Type
Table 9. List of Global Tier 1 Biodefense Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biodefense Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Biodefense Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Biodefense Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Biodefense Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Biodefense Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Biodefense Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Biodefense Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Biodefense Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Biodefense Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Biodefense Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Biodefense Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Biodefense Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Biodefense Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Biodefense Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Biodefense Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Biodefense Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Biodefense Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Biodefense Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Biodefense Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Biodefense Revenue, (US$, Mn), 2022-2027
Table 30. Emergent Biosolutions Corporate Summary
Table 31. Emergent Biosolutions Biodefense Product Offerings
Table 32. Emergent Biosolutions Biodefense Revenue (US$, Mn), (2016-2021)
Table 33. Hytest Corporate Summary
Table 34. Hytest Biodefense Product Offerings
Table 35. Hytest Biodefense Revenue (US$, Mn), (2016-2021)
Table 36. GSK Corporate Summary
Table 37. GSK Biodefense Product Offerings
Table 38. GSK Biodefense Revenue (US$, Mn), (2016-2021)
Table 39. Sanofi Corporate Summary
Table 40. Sanofi Biodefense Product Offerings
Table 41. Sanofi Biodefense Revenue (US$, Mn), (2016-2021)
Table 42. PharmAthene Corporate Summary
Table 43. PharmAthene Biodefense Product Offerings
Table 44. PharmAthene Biodefense Revenue (US$, Mn), (2016-2021)
Table 45. Bavarian Nordic Corporate Summary
Table 46. Bavarian Nordic Biodefense Product Offerings
Table 47. Bavarian Nordic Biodefense Revenue (US$, Mn), (2016-2021)
Table 48. SIGA Technologies Corporate Summary
Table 49. SIGA Technologies Biodefense Product Offerings
Table 50. SIGA Technologies Biodefense Revenue (US$, Mn), (2016-2021)
Table 51. Arbutus Biopharma Corporate Summary
Table 52. Arbutus Biopharma Biodefense Product Offerings
Table 53. Arbutus Biopharma Biodefense Revenue (US$, Mn), (2016-2021)
Table 54. DynPort Vaccine Corporate Summary
Table 55. DynPort Vaccine Biodefense Product Offerings
Table 56. DynPort Vaccine Biodefense Revenue (US$, Mn), (2016-2021)
Table 57. Xoma Corporation Corporate Summary
Table 58. Xoma Corporation Biodefense Product Offerings
Table 59. Xoma Corporation Biodefense Revenue (US$, Mn), (2016-2021)
Table 60. Ichor Medical Systems Corporate Summary
Table 61. Ichor Medical Systems Biodefense Product Offerings
Table 62. Ichor Medical Systems Biodefense Revenue (US$, Mn), (2016-2021)
Table 63. Aeolus Pharmaceuticals Corporate Summary
Table 64. Aeolus Pharmaceuticals Biodefense Product Offerings
Table 65. Aeolus Pharmaceuticals Biodefense Revenue (US$, Mn), (2016-2021)
Table 66. Achaogen Corporate Summary
Table 67. Achaogen Biodefense Product Offerings
Table 68. Achaogen Biodefense Revenue (US$, Mn), (2016-2021)
Table 69. Elusys Therapeutics Corporate Summary
Table 70. Elusys Therapeutics Biodefense Product Offerings
Table 71. Elusys Therapeutics Biodefense Revenue (US$, Mn), (2016-2021)
Table 72. Dynavax Technologies Corporate Summary
Table 73. Dynavax Technologies Biodefense Product Offerings
Table 74. Dynavax Technologies Biodefense Revenue (US$, Mn), (2016-2021)
Table 75. Cleveland BioLabs Corporate Summary
Table 76. Cleveland BioLabs Biodefense Product Offerings
Table 77. Cleveland BioLabs Biodefense Revenue (US$, Mn), (2016-2021)
Table 78. Soligenix Corporate Summary
Table 79. Soligenix Biodefense Product Offerings
Table 80. Soligenix Biodefense Revenue (US$, Mn), (2016-2021)
Table 81. Alnylam Pharmaceuticals Corporate Summary
Table 82. Alnylam Pharmaceuticals Biodefense Product Offerings
Table 83. Alnylam Pharmaceuticals Biodefense Revenue (US$, Mn), (2016-2021)
LIST OF FIGURES
Figure 1. Biodefense Segment by Type
Figure 2. Biodefense Segment by Application
Figure 3. Global Biodefense Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Biodefense Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Biodefense Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Biodefense Revenue in 2020
Figure 8. By Type - Global Biodefense Revenue Market Share, 2016-2027
Figure 9. By Application - Global Biodefense Revenue Market Share, 2016-2027
Figure 10. By Region - Global Biodefense Revenue Market Share, 2016-2027
Figure 11. By Country - North America Biodefense Revenue Market Share, 2016-2027
Figure 12. US Biodefense Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Biodefense Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Biodefense Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Biodefense Revenue Market Share, 2016-2027
Figure 16. Germany Biodefense Revenue, (US$, Mn), 2016-2027
Figure 17. France Biodefense Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Biodefense Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Biodefense Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Biodefense Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Biodefense Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Biodefense Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Biodefense Revenue Market Share, 2016-2027
Figure 24. China Biodefense Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Biodefense Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Biodefense Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Biodefense Revenue, (US$, Mn), 2016-2027
Figure 28. India Biodefense Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Biodefense Revenue Market Share, 2016-2027
Figure 30. Brazil Biodefense Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Biodefense Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Biodefense Revenue Market Share, 2016-2027
Figure 33. Turkey Biodefense Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Biodefense Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Biodefense Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Biodefense Revenue, (US$, Mn), 2016-2027
Figure 37. Emergent Biosolutions Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Hytest Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. GSK Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Sanofi Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. PharmAthene Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Bavarian Nordic Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. SIGA Technologies Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Arbutus Biopharma Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. DynPort Vaccine Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Xoma Corporation Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Ichor Medical Systems Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Aeolus Pharmaceuticals Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Achaogen Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Elusys Therapeutics Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Dynavax Technologies Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Cleveland BioLabs Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. Soligenix Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 1. Biodefense Segment by Type
Figure 2. Biodefense Segment by Application
Figure 3. Global Biodefense Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Biodefense Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Biodefense Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Biodefense Revenue in 2020
Figure 8. By Type - Global Biodefense Revenue Market Share, 2016-2027
Figure 9. By Application - Global Biodefense Revenue Market Share, 2016-2027
Figure 10. By Region - Global Biodefense Revenue Market Share, 2016-2027
Figure 11. By Country - North America Biodefense Revenue Market Share, 2016-2027
Figure 12. US Biodefense Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Biodefense Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Biodefense Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Biodefense Revenue Market Share, 2016-2027
Figure 16. Germany Biodefense Revenue, (US$, Mn), 2016-2027
Figure 17. France Biodefense Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Biodefense Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Biodefense Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Biodefense Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Biodefense Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Biodefense Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Biodefense Revenue Market Share, 2016-2027
Figure 24. China Biodefense Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Biodefense Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Biodefense Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Biodefense Revenue, (US$, Mn), 2016-2027
Figure 28. India Biodefense Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Biodefense Revenue Market Share, 2016-2027
Figure 30. Brazil Biodefense Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Biodefense Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Biodefense Revenue Market Share, 2016-2027
Figure 33. Turkey Biodefense Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Biodefense Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Biodefense Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Biodefense Revenue, (US$, Mn), 2016-2027
Figure 37. Emergent Biosolutions Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Hytest Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. GSK Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Sanofi Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. PharmAthene Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Bavarian Nordic Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. SIGA Technologies Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Arbutus Biopharma Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. DynPort Vaccine Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Xoma Corporation Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Ichor Medical Systems Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Aeolus Pharmaceuticals Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Achaogen Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Elusys Therapeutics Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Dynavax Technologies Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Cleveland BioLabs Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. Soligenix Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)